WHO Issues Guidance for Use of Casirivimab - Imdevimab in COVID - 19

Combo conditionally recommended for patients with nonsevere disease at risk for severe disease, seronegative patients with severe infection
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Family Medicine, Geriatrics, Infections, Internal Medicine, Critical Care, Emergency Medicine, Nursing, Pediatrics, Pharmacy, Pulmonology, Journal, Source Type: news